Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 285

1.

Henry J. Mankin: A Trailblazer in Skeletal Pathology Research.

Sun CM, Schwab JH, Hornicek FJ.

Spine (Phila Pa 1976). 2018 Jun 8. doi: 10.1097/BRS.0000000000002730. [Epub ahead of print]

PMID:
29889796
2.

Complications and reoperations after surgery for 647 patients with spine metastatic disease,,✯✯✯.

Pereira NRP, Ogink PT, Groot OQ, Ferrone ML, Hornicek FJ, van Dijk CN, Bramer JAM, Schwab JH.

Spine J. 2018 Jun 1. pii: S1529-9430(18)30263-8. doi: 10.1016/j.spinee.2018.05.037. [Epub ahead of print]

PMID:
29864546
3.

Lower Extremity Megaprostheses in Orthopaedic Oncology.

Lozano Calderón SA, Kuechle J, Raskin KA, Hornicek FJ.

J Am Acad Orthop Surg. 2018 Jun 15;26(12):e249-e257. doi: 10.5435/JAAOS-D-16-00218.

PMID:
29781818
4.

Expression and role of autophagy-associated p62 (SQSTM1) in multidrug resistant ovarian cancer.

Wang J, Garbutt C, Ma H, Gao P, Hornicek FJ, Kan Q, Shi H, Duan Z.

Gynecol Oncol. 2018 Jul;150(1):143-150. doi: 10.1016/j.ygyno.2018.04.557. Epub 2018 Apr 24.

PMID:
29699801
5.

CRISPR-Cas9-Mediated Silencing of CD44 in Human Highly Metastatic Osteosarcoma Cells.

Liu T, Yan Z, Liu Y, Choy E, Hornicek FJ, Mankin H, Duan Z.

Cell Physiol Biochem. 2018;46(3):1218-1230. doi: 10.1159/000489072. Epub 2018 Apr 16.

6.

Inhibition of cyclin-dependent kinase 4 as a potential therapeutic strategy for treatment of synovial sarcoma.

Li X, Seebacher NA, Garbutt C, Ma H, Gao P, Xiao T, Hornicek FJ, Duan Z.

Cell Death Dis. 2018 May 1;9(5):446. doi: 10.1038/s41419-018-0474-4.

7.

Expression and Clinical Implication of Autophagy-Associated Protein p62 in Osteosarcoma.

Ma H, Li X, Wang J, Hornicek FJ, Garbutt CC, Chang X, Duan Z.

Oncology. 2018;95(1):52-60. doi: 10.1159/000487437. Epub 2018 Apr 4.

8.

Targeting DYRK1B suppresses the proliferation and migration of liposarcoma cells.

Chen H, Shen J, Choy E, Hornicek FJ, Shan A, Duan Z.

Oncotarget. 2017 Nov 28;9(17):13154-13166. doi: 10.18632/oncotarget.22743. eCollection 2018 Mar 2.

9.

What Is the Effect of High-dose Radiation on Bone in Patients With Sacral Chordoma? A CT Study.

van Wulfften Palthe O, Jee KW, Bramer JAM, Hornicek FJ, Chen YE, Schwab JH.

Clin Orthop Relat Res. 2018 Mar;476(3):520-528. doi: 10.1007/s11999.0000000000000063.

PMID:
29529635
10.

HER4 promotes cell survival and chemoresistance in osteosarcoma via interaction with NDRG1.

Wang H, Sun W, Sun M, Fu Z, Zhou C, Wang C, Zuo D, Zhou Z, Wang G, Zhang T, Xu J, Chen J, Wang Z, Yin F, Duan Z, Hornicek FJ, Cai Z, Hua Y.

Biochim Biophys Acta. 2018 May;1864(5 Pt A):1839-1849. doi: 10.1016/j.bbadis.2018.03.008. Epub 2018 Mar 8.

PMID:
29524631
11.

Clinicopathologic characteristics of poorly differentiated chordoma.

Shih AR, Cote GM, Chebib I, Choy E, DeLaney T, Deshpande V, Hornicek FJ, Miao R, Schwab JH, Nielsen GP, Chen YL.

Mod Pathol. 2018 Feb 26. doi: 10.1038/s41379-018-0002-1. [Epub ahead of print]

PMID:
29483606
12.

Expression and therapeutic implications of cyclin-dependent kinase 4 (CDK4) in osteosarcoma.

Zhou Y, Shen JK, Yu Z, Hornicek FJ, Kan Q, Duan Z.

Biochim Biophys Acta. 2018 May;1864(5 Pt A):1573-1582. doi: 10.1016/j.bbadis.2018.02.004. Epub 2018 Feb 13.

PMID:
29452249
13.

Management of metastatic humeral fractures: Variations according to orthopedic subspecialty, tumor characteristics.

Janssen SJ, Bramer JAM, Guitton TG, Hornicek FJ, Schwab JH.

Orthop Traumatol Surg Res. 2018 Feb;104(1):59-65. doi: 10.1016/j.otsr.2017.11.008. Epub 2017 Dec 14.

PMID:
29248766
14.

CDK4 expression in chordoma: A potential therapeutic target.

Liu T, Shen JK, Choy E, Zhang Y, Mankin HJ, Hornicek FJ, Duan Z.

J Orthop Res. 2018 Jun;36(6):1581-1589. doi: 10.1002/jor.23819. Epub 2017 Dec 22.

PMID:
29194728
15.

Synovial sarcoma of the shoulder: A series of 14 cases.

Verbeek BM, Kaiser CL, Larque AB, Hornicek FJ, Raskin KA, Schwab JH, Chen YL, Lozano Calderón SA.

J Surg Oncol. 2018 Mar;117(4):788-796. doi: 10.1002/jso.24889. Epub 2017 Nov 22.

PMID:
29165811
16.

Primary arthroplasty in healed osteoarticular allograft in patients with history of primary femoral bone tumors.

Verbeek BM, Kaiser CL, Paulino Pereira NR, Hornicek FJ, Raskin KA, Schwab JH, LozanoCalderón SA.

Surg Oncol. 2017 Dec;26(4):498-505. doi: 10.1016/j.suronc.2017.10.003. Epub 2017 Oct 5.

PMID:
29113670
17.

Noncoding RNA in drug resistant sarcoma.

Li X, Shen JK, Hornicek FJ, Xiao T, Duan Z.

Oncotarget. 2017 Jul 6;8(40):69086-69104. doi: 10.18632/oncotarget.19029. eCollection 2017 Sep 15. Review.

18.

Regulation of microRNAs function by circular RNAs in human cancer.

Han C, Seebacher NA, Hornicek FJ, Kan Q, Duan Z.

Oncotarget. 2017 Aug 4;8(38):64622-64637. doi: 10.18632/oncotarget.19930. eCollection 2017 Sep 8. Review.

19.

Modified En Bloc Spondylectomy for Tumors of the Thoracic and Lumbar Spine: Surgical Technique and Outcomes.

Shah AA, Paulino Pereira NR, Pedlow FX, Wain JC, Yoon SS, Hornicek FJ, Schwab JH.

J Bone Joint Surg Am. 2017 Sep 6;99(17):1476-1484. doi: 10.2106/JBJS.17.00141.

PMID:
28872530
20.

Chordoma arising from benign multifocal notochordal tumors.

Arain A, Hornicek FJ, Schwab JH, Chebib I, Damron TA.

Skeletal Radiol. 2017 Dec;46(12):1745-1752. doi: 10.1007/s00256-017-2727-1. Epub 2017 Aug 3.

PMID:
28776089
21.

Immune Surveillance Plays a Role in Locally Aggressive Giant Cell Lesions of Bone.

Al-Sukaini A, Hornicek FJ, Peacock ZS, Kaban LB, Ferrone S, Schwab JH.

Clin Orthop Relat Res. 2017 Dec;475(12):3071-3081. doi: 10.1007/s11999-017-5451-1. Epub 2017 Jul 19.

PMID:
28725958
22.

Quality of life after resection of a chordoma of the mobile spine.

Schwab JH, Janssen SJ, Paulino Pereira NR, Chen YLE, Wain JC, DeLaney TF, Hornicek FJ.

Bone Joint J. 2017 Jul;99-B(7):979-986. doi: 10.1302/0301-620X.99B7.BJJ-2016-1126.R1.

PMID:
28663407
23.

Expression and Therapeutic Potential of SOX9 in Chordoma.

Chen H, Garbutt CC, Spentzos D, Choy E, Hornicek FJ, Duan Z.

Clin Cancer Res. 2017 Sep 1;23(17):5176-5186. doi: 10.1158/1078-0432.CCR-17-0177. Epub 2017 Jun 12.

PMID:
28606919
24.

Aberration of p73 Promoter Methylation in Chondrosarcoma.

Liu P, Garbutt C, Hornicek FJ, Liu F, Duan Z.

Anticancer Res. 2017 Jun;37(6):2939-2945.

PMID:
28551631
25.

Wnt inhibitory factor 1 (WIF1) methylation and its association with clinical prognosis in patients with chondrosarcoma.

Liu P, Shen JK, Hornicek FJ, Liu F, Duan Z.

Sci Rep. 2017 May 8;7(1):1580. doi: 10.1038/s41598-017-01763-8.

26.

The stability of the hip after the use of a proximal femoral endoprosthesis for oncological indications: analysis of variables relating to the patient and the surgical technique.

Henderson ER, Keeney BJ, Pala E, Funovics PT, Eward WC, Groundland JS, Ehrlichman LK, Puchner SS, Brigman BE, Ready JE, Temple HT, Ruggieri P, Windhager R, Letson GD, Hornicek FJ.

Bone Joint J. 2017 Apr;99-B(4):531-537. doi: 10.1302/0301-620X.99B4.BJJ-2016-0960.R1.

PMID:
28385944
27.

Vascularized Fibular Strut Autografts in Spinal Reconstruction after Resection of Vertebral Chordoma or Chondrosarcoma: A Retrospective Series.

Yanamadala V, Rozman PA, Kumar JI, Schwab JH, Lee SG, Hornicek FJ, Curry WT Jr.

Neurosurgery. 2017 Jul 1;81(1):156-164. doi: 10.1093/neuros/nyw057.

PMID:
28327915
28.

Most efficient questionnaires to measure quality of life, physical function, and pain in patients with metastatic spine disease: a cross-sectional prospective survey study.

Paulino Pereira NR, Janssen SJ, Raskin KA, Hornicek FJ, Ferrone ML, Shin JH, Bramer JAM, van Dijk CN, Schwab JH.

Spine J. 2017 Jul;17(7):953-961. doi: 10.1016/j.spinee.2017.02.006. Epub 2017 Feb 24.

PMID:
28242336
29.

NCCN Guidelines Insights: Bone Cancer, Version 2.2017.

Biermann JS, Chow W, Reed DR, Lucas D, Adkins DR, Agulnik M, Benjamin RS, Brigman B, Budd GT, Curry WT, Didwania A, Fabbri N, Hornicek FJ, Kuechle JB, Lindskog D, Mayerson J, McGarry SV, Million L, Morris CD, Movva S, O'Donnell RJ, Randall RL, Rose P, Santana VM, Satcher RL, Schwartz H, Siegel HJ, Thornton K, Villalobos V, Bergman MA, Scavone JL.

J Natl Compr Canc Netw. 2017 Feb;15(2):155-167.

PMID:
28188186
30.

Facial Layer-by-Layer Engineering of Upconversion Nanoparticles for Gene Delivery: Near-Infrared-Initiated Fluorescence Resonance Energy Transfer Tracking and Overcoming Drug Resistance in Ovarian Cancer.

Lin M, Gao Y, Diefenbach TJ, Shen JK, Hornicek FJ, Park YI, Xu F, Lu TJ, Amiji M, Duan Z.

ACS Appl Mater Interfaces. 2017 Mar 8;9(9):7941-7949. doi: 10.1021/acsami.6b15321. Epub 2017 Feb 21.

PMID:
28177223
31.

miR-15b modulates multidrug resistance in human osteosarcoma in vitro and in vivo.

Duan Z, Gao Y, Shen J, Choy E, Cote G, Harmon D, Bernstein K, Lozano-Calderon S, Mankin H, Hornicek FJ.

Mol Oncol. 2017 Feb;11(2):151-166. doi: 10.1002/1878-0261.12015. Epub 2016 Oct 24.

32.

Updated Outcome and Analysis of Tumor Response in Mobile Spine and Sacral Chordoma Treated With Definitive High-Dose Photon/Proton Radiation Therapy.

Kabolizadeh P, Chen YL, Liebsch N, Hornicek FJ, Schwab JH, Choy E, Rosenthal DI, Niemierko A, DeLaney TF.

Int J Radiat Oncol Biol Phys. 2017 Feb 1;97(2):254-262. doi: 10.1016/j.ijrobp.2016.10.006. Epub 2016 Oct 13.

PMID:
27986348
33.

Regulation of microRNA-1 (miR-1) expression in human cancer.

Han C, Shen JK, Hornicek FJ, Kan Q, Duan Z.

Biochim Biophys Acta. 2017 Feb;1860(2):227-232. doi: 10.1016/j.bbagrm.2016.12.004. Epub 2016 Dec 5. Review.

PMID:
27923712
34.

Functional and oncological outcome after surgical resection of the scapula and clavicle for primary chondrosarcoma.

Nota SP, Russchen MJ, Raskin KA, Mankin HJ, Hornicek FJ, Schwab JH.

Musculoskelet Surg. 2017 Apr;101(1):67-73. doi: 10.1007/s12306-016-0437-9. Epub 2016 Nov 29.

PMID:
27900545
35.

Are perioperative allogeneic blood transfusions associated with 90-days infection after operative treatment for bone metastases?

Paulino Pereira NR, Langerhuizen DW, Janssen SJ, Hornicek FJ, Ferrone ML, Harris MB, Schwab JH.

J Surg Oncol. 2016 Dec;114(8):997-1003. doi: 10.1002/jso.24440. Epub 2016 Nov 18.

PMID:
27859275
36.

What questionnaires to use when measuring quality of life in sacral tumor patients: the updated sacral tumor survey.

van Wulfften Palthe ODR, Janssen SJ, Wunder JS, Ferguson PC, Wei G, Rose PS, Yaszemski MJ, Sim FH, Boland PJ, Healey JH, Hornicek FJ, Schwab JH.

Spine J. 2017 May;17(5):636-644. doi: 10.1016/j.spinee.2016.11.004. Epub 2016 Nov 14.

37.

Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance.

Liu T, Li Z, Zhang Q, De Amorim Bernstein K, Lozano-Calderon S, Choy E, Hornicek FJ, Duan Z.

Oncotarget. 2016 Dec 13;7(50):83502-83513. doi: 10.18632/oncotarget.13148. Review.

38.

Development of a Prognostic Survival Algorithm for Patients with Metastatic Spine Disease.

Paulino Pereira NR, Janssen SJ, van Dijk E, Harris MB, Hornicek FJ, Ferrone ML, Schwab JH.

J Bone Joint Surg Am. 2016 Nov 2;98(21):1767-1776.

PMID:
27807108
39.

Aberrant DNA methylations in chondrosarcoma.

Liu P, Shen JK, Xu J, Trahan CA, Hornicek FJ, Duan Z.

Epigenomics. 2016 Nov;8(11):1519-1525. Epub 2016 Sep 30. Review.

40.

Clinical outcomes for patients after surgery and radiation therapy for mesenchymal chondrosarcomas.

De Amorim Bernstein K, Liebsch N, Chen YL, Niemierko A, Schwab JH, Raskin K, Lozano-Calderon SA, Cote G, Harmon DC, Choy E, Haynes A, Mullen J, Hornicek FJ, DeLaney TF.

J Surg Oncol. 2016 Dec;114(8):982-986. doi: 10.1002/jso.24435. Epub 2016 Oct 28.

PMID:
27790706
41.

A comparison of questionnaires for assessing physical function in patients with lower extremity bone metastases.

Janssen SJ, Paulino Pereira NR, Raskin KA, Ferrone ML, Hornicek FJ, van Dijk CN, Lozano-Calderón SA, Schwab JH.

J Surg Oncol. 2016 Nov;114(6):691-696. doi: 10.1002/jso.24400. Epub 2016 Aug 11.

PMID:
27511611
42.

The emerging roles and therapeutic potential of cyclin-dependent kinase 11 (CDK11) in human cancer.

Zhou Y, Shen JK, Hornicek FJ, Kan Q, Duan Z.

Oncotarget. 2016 Jun 28;7(26):40846-40859. doi: 10.18632/oncotarget.8519. Review.

43.

Novel mechanisms and approaches to overcome multidrug resistance in the treatment of ovarian cancer.

Ren F, Shen J, Shi H, Hornicek FJ, Kan Q, Duan Z.

Biochim Biophys Acta. 2016 Dec;1866(2):266-275. doi: 10.1016/j.bbcan.2016.10.001. Epub 2016 Oct 4. Review.

PMID:
27717733
44.

What Factors are Associated With Quality Of Life, Pain Interference, Anxiety, and Depression in Patients With Metastatic Bone Disease?

van der Vliet QM, Paulino Pereira NR, Janssen SJ, Hornicek FJ, Ferrone ML, Bramer JA, van Dijk CN, Schwab JH.

Clin Orthop Relat Res. 2017 Feb;475(2):498-507. doi: 10.1007/s11999-016-5118-3. Epub 2016 Oct 17.

45.

The Discrepancy between Patient and Clinician Reported Function in Extremity Bone Metastases.

Janssen SJ, van Rein EA, Paulino Pereira NR, Raskin KA, Ferrone ML, Hornicek FJ, Lozano-Calderon SA, Schwab JH.

Sarcoma. 2016;2016:1014248. Epub 2016 Sep 20.

46.

CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 26-2016. A 28-Year-Old Woman with Back Pain and a Lesion in the Lumbar Spine.

Choy E, Hornicek FJ, Chen YL, Rosenthal DI, Kerr DA.

N Engl J Med. 2016 Aug 25;375(8):779-88. doi: 10.1056/NEJMcpc1505482. No abstract available.

PMID:
27557305
47.

Genetic Analysis of Giant Cell Lesions of the Maxillofacial and Axial/Appendicular Skeletons.

Peacock ZS, Schwab JH, Faquin WC, Hornicek FJ, Benita Y, Ebb DH, Kaban LB.

J Oral Maxillofac Surg. 2017 Feb;75(2):298-308. doi: 10.1016/j.joms.2016.07.014. Epub 2016 Jul 26.

PMID:
27546031
48.

Outcome after fixation of metastatic proximal femoral fractures: A systematic review of 40 studies.

Janssen SJ, Teunis T, Hornicek FJ, van Dijk CN, Bramer JA, Schwab JH.

J Surg Oncol. 2016 Sep;114(4):507-19. doi: 10.1002/jso.24345. Epub 2016 Jul 3. Review.

PMID:
27374478
49.

Complications After Surgical Management of Proximal Femoral Metastasis: A Retrospective Study of 417 Patients.

Janssen SJ, Kortlever JT, Ready JE, Raskin KA, Ferrone ML, Hornicek FJ, Lozano-Calderon SA, Schwab JH.

J Am Acad Orthop Surg. 2016 Jul;24(7):483-94. doi: 10.5435/JAAOS-D-16-00043.

PMID:
27227983
50.

Cyclin-Dependent Kinase 11 (CDK11) Is Required for Ovarian Cancer Cell Growth In Vitro and In Vivo, and Its Inhibition Causes Apoptosis and Sensitizes Cells to Paclitaxel.

Liu X, Gao Y, Shen J, Yang W, Choy E, Mankin H, Hornicek FJ, Duan Z.

Mol Cancer Ther. 2016 Jul;15(7):1691-701. doi: 10.1158/1535-7163.MCT-16-0032. Epub 2016 May 20.

Supplemental Content

Loading ...
Support Center